Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Nov 1;184(5):2007–2012. doi: 10.1084/jem.184.5.2007

A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes

PMCID: PMC2192854  PMID: 8920887

Abstract

Psoriasis is a common chronic skin disease mediated by cellular immune mechanisms and characterized by an intense neutrophil cell infiltrate and proliferative activation of epidermal keratinocytes. We have previously described the expression of the inducible nitric oxide synthase (iNOS) in epidermal keratinocytes of psoriatic skin lesions. In this study, the role of iNOS in psoriatic inflammation was explored ex vivo in psoriatic skin biopsies and in vitro in primary cultures of human keratinocytes. Messenger RNA for the iNOS enzyme (iNOS mRNA) was detected by reverse transcriptase polymerase chain reaction in skin biopsies from patients with psoriasis, but not in skin specimens from patients with atopic eczema or from healthy volunteers. As demonstrated by in situ hybridization and immunohistochemistry, expression of iNOS mRNA and its gene product was localized to the epidermal keratinocytes of psoriatic skin lesions. In situ hybridization further revealed a complete colocalization of mRNA expression for iNOS with interleukin (IL) 8 receptor-specific mRNA either in the basal germinative cell layer or at focal sites of ongoing neutrophil inflammation in suprabasal cell layers. Because psoriatic keratinocytes have previously been shown to express mRNA transcripts for IL-8, it seemed reasonable to hypothesize that iNOS expression could be induced in an autocrine loop by IL-8. This hypothesis was substantiated by our in vitro experiments showing that a combination of IL-8 and interferon gamma induces the expression of iNOS-specific mRNA and of the functional enzyme in cultured human keratinocytes. These results suggest an important role for iNOS in concert with IL-8 and its receptor early during the formation of psoriatic lesions.

Full Text

The Full Text of this article is available as a PDF (814.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi K., Aoyagi T., Nemoto O., Halprin K. M., Levine V. Epidermal cyclic GMP is increased in psoriasis lesions. J Invest Dermatol. 1981 Jan;76(1):19–20. doi: 10.1111/1523-1747.ep12524471. [DOI] [PubMed] [Google Scholar]
  2. Amin A. R., Di Cesare P. E., Vyas P., Attur M., Tzeng E., Billiar T. R., Stuchin S. A., Abramson S. B. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med. 1995 Dec 1;182(6):2097–2102. doi: 10.1084/jem.182.6.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anggård E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994 May 14;343(8907):1199–1206. doi: 10.1016/s0140-6736(94)92405-8. [DOI] [PubMed] [Google Scholar]
  4. Barker J. N., Mitra R. S., Griffiths C. E., Dixit V. M., Nickoloff B. J. Keratinocytes as initiators of inflammation. Lancet. 1991 Jan 26;337(8735):211–214. doi: 10.1016/0140-6736(91)92168-2. [DOI] [PubMed] [Google Scholar]
  5. Bos J. D., Kapsenberg M. L. The skin immune system: progress in cutaneous biology. Immunol Today. 1993 Feb;14(2):75–78. doi: 10.1016/0167-5699(93)90062-P. [DOI] [PubMed] [Google Scholar]
  6. Bécherel P. A., Mossalayi M. D., LeGoff L., Francès C., Chosidow O., Debré P., Arock M. Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet. 1994 Dec 3;344(8936):1570–1571. doi: 10.1016/s0140-6736(94)90377-8. [DOI] [PubMed] [Google Scholar]
  7. Gillitzer R., Berger R., Mielke V., Müller C., Wolff K., Stingl G. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol. 1991 Jul;97(1):73–79. doi: 10.1111/1523-1747.ep12478128. [DOI] [PubMed] [Google Scholar]
  8. Kemény L., Kenderessy A. S., Ocsovszky I., Michel G., Ruzicka T., Dobozy A. Interleukin-8 induces HLA-DR expression on cultured human keratinocytes via specific receptors. Int Arch Allergy Immunol. 1995 Apr;106(4):351–356. doi: 10.1159/000236866. [DOI] [PubMed] [Google Scholar]
  9. Kemény L., Kenderessy A. S., Olasz E., Michel G., Ruzicka T., Farkas B., Dobozy A. The interleukin-8 receptor: a potential target for antipsoriatic therapy? Eur J Pharmacol. 1994 Jun 13;258(3):269–272. doi: 10.1016/0014-2999(94)90490-1. [DOI] [PubMed] [Google Scholar]
  10. Kolb-Bachofen V., Fehsel K., Michel G., Ruzicka T. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet. 1994 Jul 9;344(8915):139–139. doi: 10.1016/s0140-6736(94)91328-5. [DOI] [PubMed] [Google Scholar]
  11. Kolb H., Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today. 1992 May;13(5):157–160. doi: 10.1016/0167-5699(92)90118-Q. [DOI] [PubMed] [Google Scholar]
  12. Kröncke K. D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe Seyler. 1995 Jun;376(6):327–343. doi: 10.1515/bchm3.1995.376.6.327. [DOI] [PubMed] [Google Scholar]
  13. McCall T. B., Palmer R. M., Moncada S. Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem Biophys Res Commun. 1992 Jul 31;186(2):680–685. doi: 10.1016/0006-291x(92)90800-z. [DOI] [PubMed] [Google Scholar]
  14. Michel G., Kemeny L., Homey B., Ruzicka T. FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol Today. 1996 Mar;17(3):106–108. doi: 10.1016/0167-5699(96)80599-8. [DOI] [PubMed] [Google Scholar]
  15. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  16. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
  17. Nickoloff B. J., Karabin G. D., Barker J. N., Griffiths C. E., Sarma V., Mitra R. S., Elder J. T., Kunkel S. L., Dixit V. M. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 1991 Jan;138(1):129–140. [PMC free article] [PubMed] [Google Scholar]
  18. Nussler A. K., Billiar T. R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol. 1993 Aug;54(2):171–178. [PubMed] [Google Scholar]
  19. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 1995 May 4;375(6526):68–73. doi: 10.1038/375068a0. [DOI] [PubMed] [Google Scholar]
  20. Schlaak J. F., Buslau M., Jochum W., Hermann E., Girndt M., Gallati H., Meyer zum Büschenfelde K. H., Fleischer B. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol. 1994 Feb;102(2):145–149. doi: 10.1111/1523-1747.ep12371752. [DOI] [PubMed] [Google Scholar]
  21. Schmidt H. H., Walter U. NO at work. Cell. 1994 Sep 23;78(6):919–925. doi: 10.1016/0092-8674(94)90267-4. [DOI] [PubMed] [Google Scholar]
  22. Schulz B. S., Michel G., Wagner S., Süss R., Beetz A., Peter R. U., Kemény L., Ruzicka T. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol. 1993 Oct 15;151(8):4399–4406. [PubMed] [Google Scholar]
  23. Xie Q. W., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992 Apr 10;256(5054):225–228. doi: 10.1126/science.1373522. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES